VERO Stock Catalyst: Venus Concept Receives FDA Clearance for Venus NOVA Platform

Nov 10, 2025 · 7:30am ET

The clearance allows for the marketing of a new non-invasive treatment.

Max move

+59.9%

High of day $3.63

Sparker timei

7:30am ET

VERO · Nov 10, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Venus Concept Inc. announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Venus NOVA platform. This platform is designed for non-invasive body and skin treatments.

The clearance permits Venus Concept to market the Venus NOVA for various aesthetic procedures without the need for surgery.

With approximately 1,624,400 shares in free float, the company continues to expand its product offerings in the medical devices sector.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time VERO sparks.

Download Sniper App →

Catch the next VERO-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →